Steel Grove Capital Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Steel Grove Capital Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-987,000	Closed	-$162K	–	201
2022 Q4	$162K	Buy	987,000 +794,000	+411%	+$332K	0.02%	172
2022 Q3	$125K	Buy	193,000 +183,000	+1,830%	+$270K	0.02%	147
2022 Q2	$24K	Buy	+10,000	New	+$27.8K	﹤0.01%	141
2022 Q1	–	Sell	-5,800	Closed	-$46K	–	164
2021 Q4	$46K	Buy	+5,800	New	+$68K	0.01%	148

Other funds holding PLXP

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

Steel Grove Capital Advisors's PLXP Position: Q1 2023 in Review

Steel Grove Capital Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 987,000 shares — an estimated $162K sold.

Steel Grove Capital Advisors first reported a position in PLXP in Q4 2021 and held it in 4 quarters. The position peaked at $162K in Q4 2022. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

Steel Grove Capital Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Steel Grove Capital Advisors sold 987,000 PLx Pharma Inc. Common Stock shares in Q1 2023, an estimated $162K.
Steel Grove Capital Advisors first reported a position in PLx Pharma Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Steel Grove Capital Advisors's PLx Pharma Inc. Common Stock position peaked at $162K in Q4 2022.
34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on Steel Grove Capital Advisors's 13F filing for Q1 2023, filed 14 Apr 2023.